Clinical Trial: Geriatric Assessmen of Elderly "Unsuited" Patients Receiving Trabectedin in First Line Treatment For Advanced Soft Tissue Sarcomas (STS)

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational

Official Title: Geriatric Assessmen of Elderly "Unsuited" Patients Receiving Trabectedin in First Line Treatment For Advanced Soft Tissue Sarcomas (STS)

Brief Summary:

The aim of the non-interventional study is to prospectively collect and analyze data on the geriatric assessment of patients undergoing systemic 1st line therapy with trabectedin with focus on patients who have been assessed by the treating physician as being unsuited to receive standard chemotherapy with anthracyclines and / or ifosfamide.

Trabectedin will be used according to the local SmPC. Modification of the treatment schedule should follow the standard medical practice at the discretion of the treating physician and is not part of this Observational Plan.


Detailed Summary:
Sponsor: GWT-TUD GmbH

Current Primary Outcome: Overall survival [ Time Frame: 12 month after LPFV ]

Overall survival for each patient will be followed until the end of the study that is defined by 12 months after inclusion of the last patient.


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: GWT-TUD GmbH

Dates:
Date Received: January 13, 2017
Date Started: January 2017
Date Completion: January 2021
Last Updated: February 13, 2017
Last Verified: February 2017